Investors

Media

Welcome to the new Regeneron Newsroom. This newsroom is designed to provide members of the media with easy access to up-to-date information about the Company.

For an e-mail response to questions about Regeneron, please contact us at media@regeneron.com.



Upcoming Events

Aug 4, 2016
8:30 AM ET
Webcast Regeneron Pharmaceuticals Q2 2016 Earnings Conference Call
Aug 11, 2016
11:30 AM ET
Webcast 36th Annual Canaccord Genuity Growth Conference


View all releases Recent Press Releases

Jul 18, 2016 Regeneron Announces Upcoming 2016 Investor Conference Presentation
Jul 13, 2016 Regeneron Announces 2016 Winners of the Regeneron Prize for Creative Innovation
Jul 12, 2016 Award-Winning Chef Elizabeth Falkner Reveals Her Struggle with Atopic Dermatitis to Highlight the Physical and Psychological Impact of the Disease
Jul 8, 2016 Regeneron to Report Second Quarter 2016 Financial and Operating Results and Host Conference Call and Webcast on August 4, 2016
Jul 5, 2016 Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Jun 6, 2016 Regeneron and Sanofi Announce that Dupilumab Used with Topical Corticosteroids (TCS) was Superior to Treatment with TCS Alone in Long-term Phase 3 Trial in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients
May 31, 2016 Regeneron Presents Positive Interim Data from Phase 2 Proof-of-Concept Study of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia
May 26, 2016 Regeneron Selected by Society for Science & the Public as New Sponsor of the Science Talent Search
May 26, 2016 Words of Support from Public Figures on Regeneron STS Sponsorship
May 25, 2016 Regeneron Announces Important US Prescribing Information Clarification for EYLEA® (aflibercept) Injection


Close
Form content here please :)